SHENZHEN QIANHAI BEIZENG ASSET MANAGEMENT
Shenzhen Qianhai Beizeng Asset Management is an investment Firm.
SHENZHEN QIANHAI BEIZENG ASSET MANAGEMENT
Status:
Active
Similar Organizations
Shenzhen Qiahai Caishi Investment Management
Shenzhen Qiahai Caishi Investment Management is an investment Firm.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-02 | Sanyou Bio | Shenzhen Qianhai Beizeng Asset Management investment in Series B - Sanyou Bio | N/A |
| 2021-11-15 | Jisi Yingda | Shenzhen Qianhai Beizeng Asset Management investment in Series B - Jisi Yingda | N/A |
| 2021-08-17 | Hisky Medical | Shenzhen Qianhai Beizeng Asset Management investment in Series B - Hisky Medical | 100 M CNY |
| 2019-07-05 | Zhongyianke Biotech | Shenzhen Qianhai Beizeng Asset Management investment in Series A - Zhongyianke Biotech | 36 M USD |
More informations about "Shenzhen Qianhai Beizeng Asset Management"
Qianhai Beizeng - Crunchbase Investor Profile & Investments
Qianhai Beizeng is an investment management company that offers equity investment fund management focusing on the field of big health. Search Crunchbase. ... Also Known As 贝增资 …See details»
Shenzhen Qianhai Beizeng Asset Management
Shenzhen Qianhai Beizeng Asset Management is an investment Firm.See details»
Shenzhen Qianhai Beizeng Asset Management - CB Insights
The firm invests in companies of all stages in healthcare, environmental protection, and new material industries. Use the CB Insights Platform to explore Shenzhen Qianhai Beizeng Asset …See details»
Shenzhen Qianhai Beizeng Asset Management - Crunchbase
Dec 13, 2022 Shenzhen Qianhai Beizeng Asset Management has made 6 investments. Their most recent investment was on Dec 13, 2022, when ... How many investments has this …See details»
Shenzhen Qianhai Beizeng Investor Profile: Portfolio & Exits
Nov 15, 2021 Shenzhen Qianhai Beizeng General Information Company Description. Founded in 2016, Shenzhen Qianhai Beizeng is a growth equity firm based in Chengdu, China. The firm …See details»
Zhongyianke Bio Raises $36 Million to Expand Vaccine …
Jul 5, 2019 Zhongyianke Biotech, a Tianjin vaccine maker, raised $36 million in a Series A financing led by Shenzhen Qianhai Beizeng Asset Management. Founded in 2001, Zhongyianke has launched a flu vaccine and is conducting …See details»
Sanyou Biopharmaceuticals Closed the Series B+ Financing Round …
Aug 3, 2022 Shenzhen Qianhai Beizeng Asset Management Co., Ltd. focuses on investment in the comprehensive field of health. The founder has been engaged in the management of R&D …See details»
Qianhai Beizeng Asset Management investor portfolio, rounds
Qianhai Beizeng Asset Management Venture capital Claimed. Overview. Portfolio (0) Notes. Recent News about Qianhai Beizeng Asset Management Edit. Portfolio analysis ...See details»
Shenzhen Qianhai Beizeng Asset Management — 4 Investments, …
Shenzhen Qianhai Beizeng Asset Management. Search. Overview Investments Unlock datapoints. Portfolio analytics Team News & Media. Add fund to favorites. Save this fund for …See details»
Trusted Asset Management (Chinese companies list)
Other organizational management services ... Securities Asset Management And Other Services ... Shenzhen Qianhai Qingzhou Capital Management Co., Ltd. Founding date. 2015-04-29. …See details»
Qianhai Beizeng Asset Management - VC Firm Profile
Qianhai Beizeng Asset Management is a VC investing group that helps tech companies seeking to achieve their full potential. Venture Investor Overview. Venture Investor. Qianhai Beizeng …See details»
CRO GX Pharma Nets Over CNY 100 Mn in Series B+ - EqualOcean
Dec 13, 2022 GX Pharma (Chinese: 国信医药), a clinical research organization (CRO), announced that it had completed a CNY 100 million (USD 14.35 million ) Series B+ round of …See details»
Shenzhen Qianhai Beizeng Asset Management - Crunchbase
Shenzhen Qianhai Beizeng Asset Management is engaged in entrusted asset management and investment management.See details»
GX Pharma - Products, Competitors, Financials, Employees, …
Investors of GX Pharma include In Capital, Shenzhen Qianhai Beizeng Asset Management, Richmont Capital Partners, Zhongguancun Bank, Guoju Investment and 5 more. Loading...See details»
Sanyou Biopharmaceuticals Closed the Series B+ Financing
Aug 2, 2022 Shenzhen Qianhai Beizeng Asset Management Co., Ltd. focuses on investment in the comprehensive field of health. The founder has been engaged in the management of R&D …See details»
Financial Services and the Treasury Bureau and Shenzhen Qianhai ...
Sep 2, 2022 To support the linked development of Shenzhen and Hong Kong venture capital (VC) investments, promote Shenzhen-Hong Kong co-operation on innovation and technology …See details»
Insights - China Hedge Funds Add $200 Billion, Trouncing Wall …
Feb 8, 2021 Shenzhen Qianhai Jianhong Times Asset Management added leveraged bets on stocks seen to benefit from the pandemic, such as glove makers and office supply companies …See details»
China's QDIE scheme goes live | Asia Asset Management
The QDIE scheme is implemented in Qianhai; a special economic zone in Shenzhen that has been established as a testing ground for Chinese financial reforms. It allows Mainland …See details»
Shenzhen Qianhai Beizeng Asset Management - Crunchbase
Shenzhen Qianhai Beizeng Asset Management is an investment Firm.See details»